April 17, 2018
Allergan Inc. will pay $3.5 million to settle allegations it sold defective Lap-Band weight loss devices and promoted the product for procedures not medically reasonable or necessary, resulting in false claims for reimbursement from federal health care programs, the U.S. Department of Justice announced.